Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fundamental limits to graphene plasmonics.
Ni GX, McLeod AS, Sun Z, Wang L, Xiong L, Post KW, Sunku SS, Jiang BY, Hone J, Dean CR, Fogler MM, Basov DN. Ni GX, et al. Among authors: jiang by. Nature. 2018 May;557(7706):530-533. doi: 10.1038/s41586-018-0136-9. Epub 2018 May 23. Nature. 2018. PMID: 29795255
Soliton superlattices in twisted hexagonal boron nitride.
Ni GX, Wang H, Jiang BY, Chen LX, Du Y, Sun ZY, Goldflam MD, Frenzel AJ, Xie XM, Fogler MM, Basov DN. Ni GX, et al. Among authors: jiang by. Nat Commun. 2019 Sep 25;10(1):4360. doi: 10.1038/s41467-019-12327-x. Nat Commun. 2019. PMID: 31554808 Free PMC article.
Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study.
Lin JT, Li XM, Zhong WZ, Hou QY, Liu CL, Yu XY, Ye KY, Cheng YL, Du JY, Sun YQ, Zhang FG, Yan HH, Liao RQ, Dong S, Jiang BY, Liu SY, Wu YL, Yang XN. Lin JT, et al. Among authors: jiang by. Ann Nucl Med. 2024 Mar;38(3):188-198. doi: 10.1007/s12149-023-01888-z. Epub 2023 Dec 25. Ann Nucl Med. 2024. PMID: 38145431
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.
Liu SY, Dong S, Yang XN, Liao RQ, Jiang BY, Wang Q, Ben XS, Qiao GB, Lin JT, Yan HH, Yan LX, Nie Q, Tu HY, Wang BC, Yang JJ, Zhou Q, Li HR, Liu K, Wu W, Liu SM, Zhong WZ, Wu YL. Liu SY, et al. Among authors: jiang by. Signal Transduct Target Ther. 2023 Dec 6;8(1):442. doi: 10.1038/s41392-023-01700-4. Signal Transduct Target Ther. 2023. PMID: 38057314 Free PMC article. Clinical Trial.
96 results